by Stacey Johnson | May 31, 2013
Metaphorically speaking, Signals Blog has put its money where its mouth is by creating an infographic to demonstrate how easy it is to create one for our “Everybody loves infographics” contest. Two weeks ago Signals Blog launched its first contest, with an iPad mini...
by Sara M. Nolte | May 30, 2013
. My interest (maybe even fascination) in cancer began when I was six years old: I was diagnosed with acute myeloblastic leukemia (a cancer of white blood cells), and am now able to say that I am a childhood cancer survivor. After realizing that I was no longer...
by David Kent | May 28, 2013
. A few weeks ago, Italian private company Stamina came under considerable pressure regarding their controversial use of mesenchymal stem cells in patients. The Italian government, it seems, had authorized an unproven stem cell therapy for use in patients. The...
by Lisa Willemse | May 24, 2013
Co-authored with Dr. Zubin Master, Assistant Professor at the Alden March Bioethics Institute, Albany Medical College and Research Associate at the University of Alberta’s Health Law and Science Policy Group. In the current discussion about the now controversial...
by Lisa Willemse | May 24, 2013
. This is an anniversary celebration of sorts. One year ago (almost to the day), EuroStemCell and OptiStem released the graphic story From Hope to Hype and I recall being amazed: not just at the beauty and integrity of the finished product, but at the immense...
Comments